PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
16-Feb-2024 Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results Businesswire
16-Feb-2024 AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million Businesswire
16-Feb-2024 Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights Businesswire
16-Feb-2024 Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products Businesswire
15-Feb-2024 Preclinical Data on PIV5-based Intranasal Vaccine Against Lyme Disease Demonstrates Durable Immune Response Businesswire
15-Feb-2024 Kurome Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KME-0584 for the Treatment of Acute Myeloid Lymphoma (AML) and High-Risk Myelodysplastic Syndromes (MDS) Businesswire
15-Feb-2024 Meatable Strengthens Board of Directors to Accelerate Growth of Breakthrough Food Technology Businesswire
15-Feb-2024 Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approval of VIGZIP™ (vigabatrin oral solution) Businesswire
15-Feb-2024 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of The Children's Place, Inc. (PLCE) on Behalf of Investors Businesswire
15-Feb-2024 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of InMode Ltd. (INMD) on Behalf of Investors Businesswire
15-Feb-2024 Areteia Therapeutics gibt Ernennung von Daniel Becker, M.D., Ph.D. in Areteia Board of Directors bekannt Businesswire
15-Feb-2024 Global Actuators Strategic Industry Report 2024: Reach $108.7 Billion by 2030 - Smart Cities Emerge as Major Opportunity - ResearchAndMarkets.com Businesswire
15-Feb-2024 MedinCell to Present at the Evercore ISI 2024 Emerging Biotech Conference Businesswire
15-Feb-2024 Areteia Therapeutics annonce la nomination de Daniel Becker, M.D., Ph.D. au conseil d'administration Businesswire
15-Feb-2024 INMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Businesswire
15-Feb-2024 INDM INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Businesswire
15-Feb-2024 eClinical Solutions Highlights Notable Year of Growth Supporting Biopharma's Complex Data Demands Businesswire
15-Feb-2024 Simulations Plus Extends Collaboration with Major Toxicology Research Agency Businesswire
15-Feb-2024 Lantern Pharma Advances Unique ADC (Antibody Drug Conjugate) Program Across Multiple Solid Tumor Cancers Businesswire
15-Feb-2024 Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer Businesswire